These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 12621135

  • 1. Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature.
    Yanovski JA, Rose SR, Municchi G, Pescovitz OH, Hill SC, Cassorla FG, Cutler GB.
    N Engl J Med; 2003 Mar 06; 348(10):908-17. PubMed ID: 12621135
    [Abstract] [Full Text] [Related]

  • 2. Combined use of growth hormone and gonadotropin-releasing hormone analogue in short normal adolescent girls: a survey from Iran.
    Karamizadeh Z, Kashef MA, Jalaeian H, Namazee N.
    Kaohsiung J Med Sci; 2006 Apr 06; 22(4):161-5. PubMed ID: 16679296
    [Abstract] [Full Text] [Related]

  • 3. Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment?
    Léger J, Reynaud R, Czernichow P.
    J Pediatr; 2000 Dec 06; 137(6):819-25. PubMed ID: 11113839
    [Abstract] [Full Text] [Related]

  • 4. Effect of growth hormone treatment on adult height of children with idiopathic short stature. Genentech Collaborative Group.
    Hintz RL, Attie KM, Baptista J, Roche A.
    N Engl J Med; 1999 Feb 18; 340(7):502-7. PubMed ID: 10021470
    [Abstract] [Full Text] [Related]

  • 5. Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. Effects on somatic growth and skeletal maturation.
    Mansfield MJ, Beardsworth DE, Loughlin JS, Crawford JD, Bode HH, Rivier J, Vale W, Kushner DC, Crigler JF, Crowley WF.
    N Engl J Med; 1983 Nov 24; 309(21):1286-90. PubMed ID: 6415479
    [Abstract] [Full Text] [Related]

  • 6. Effect of growth hormone treatment on the adult height of children with chronic renal failure. German Study Group for Growth Hormone Treatment in Chronic Renal Failure.
    Haffner D, Schaefer F, Nissel R, Wühl E, Tönshoff B, Mehls O.
    N Engl J Med; 2000 Sep 28; 343(13):923-30. PubMed ID: 11006368
    [Abstract] [Full Text] [Related]

  • 7. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.
    Lanes R, Gunczler P.
    Clin Endocrinol (Oxf); 1998 Aug 28; 49(2):197-202. PubMed ID: 9828907
    [Abstract] [Full Text] [Related]

  • 8. Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone release hormone (D-Tryp6-GnRH) in monthly injections. Its possible use in normal puberty.
    Marcondes JA, Abujamra AC, Minanni SL, Mendonca BB, Nery M, Lerario AC, Pereira MA, Abelin N, Wajchenberg BL.
    Horm Metab Res; 1993 Feb 28; 25(2):105-9. PubMed ID: 8458605
    [Abstract] [Full Text] [Related]

  • 9. Growth outcome during GnRH agonist treatments for slowly progressive central precocious puberty.
    Massart F, Federico G, Harrell JC, Saggese G.
    Neuroendocrinology; 2009 Feb 28; 90(3):307-14. PubMed ID: 19641297
    [Abstract] [Full Text] [Related]

  • 10. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM, Pucarelli I, Roggini M, Segni M.
    J Clin Endocrinol Metab; 2000 Feb 28; 85(2):619-22. PubMed ID: 10690865
    [Abstract] [Full Text] [Related]

  • 11. Effect of deslorelin-induced pubertal delay on the growth of adolescents with short stature and normally timed puberty: preliminary results.
    Municchi G, Rose SR, Pescovitz OH, Barnes KM, Cassorla FG, Cutler GB.
    J Clin Endocrinol Metab; 1993 Nov 28; 77(5):1334-9. PubMed ID: 8077329
    [Abstract] [Full Text] [Related]

  • 12. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W, Briody J, Moore B, Lu PW, Cowell CT.
    Bone; 2005 Nov 28; 37(5):642-50. PubMed ID: 16139578
    [Abstract] [Full Text] [Related]

  • 13. Final height outcome after three years of growth hormone and gonadotropin-releasing hormone agonist treatment in short adolescents with relatively early puberty.
    van Gool SA, Kamp GA, Visser-van Balen H, Mul D, Waelkens JJ, Jansen M, Verhoeven-Wind L, Delemarre-van de Waal HA, de Muinck Keizer-Schrama SM, Leusink G, Roos JC, Wit JM.
    J Clin Endocrinol Metab; 2007 Apr 28; 92(4):1402-8. PubMed ID: 17284626
    [Abstract] [Full Text] [Related]

  • 14. Final height after treatment of early puberty in short adopted girls with gonadotrophin releasing hormone agonist with or without growth hormone.
    Mul D, Oostdijk W, Waelkens JJ, Drop SL.
    Clin Endocrinol (Oxf); 2005 Aug 28; 63(2):185-90. PubMed ID: 16060912
    [Abstract] [Full Text] [Related]

  • 15. Combined use of growth hormone and gonadotropin-releasing hormone analogues: the national cooperative growth study experience.
    Kohn B, Julius JR, Blethen SL.
    Pediatrics; 1999 Oct 28; 104(4 Pt 2):1014-8. PubMed ID: 10506254
    [Abstract] [Full Text] [Related]

  • 16. Adult height in precocious puberty after long-term treatment with deslorelin.
    Oerter KE, Manasco P, Barnes KM, Jones J, Hill S, Cutler GB.
    J Clin Endocrinol Metab; 1991 Dec 28; 73(6):1235-40. PubMed ID: 1955504
    [Abstract] [Full Text] [Related]

  • 17. Luteinizing hormone-releasing hormone agonist triptorelin in combination with cytotoxic chemotherapy in patients with advanced ovarian carcinoma. A prospective double blind randomized trial. Decapeptyl Ovarian Cancer Study Group.
    Emons G, Ortmann O, Teichert HM, Fassl H, Löhrs U, Kullander S, Kauppila A, Ayalon D, Schally A, Oberheuser F.
    Cancer; 1996 Oct 01; 78(7):1452-60. PubMed ID: 8839551
    [Abstract] [Full Text] [Related]

  • 18. Effect of long-term growth hormone therapy on bone age and pubertal maturation in boys with and without classic growth hormone deficiency.
    Zadik Z, Chalew S, Zung A, Landau H, Leiberman E, Koren R, Voet H, Hochberg Z, Kowarski AA.
    J Pediatr; 1994 Aug 01; 125(2):189-95. PubMed ID: 8040760
    [Abstract] [Full Text] [Related]

  • 19. Growth, bone maturation and height prediction after three years of therapy with the slow release GnRH-agonist Decapeptyl-Depot in children with central precocious puberty.
    Hümmelink R, Oostdijk W, Partsch CJ, Odink RJ, Drop SL, Sippell WG.
    Horm Metab Res; 1992 Mar 01; 24(3):122-6. PubMed ID: 1533604
    [Abstract] [Full Text] [Related]

  • 20. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
    Kamp GA, Mul D, Waelkens JJ, Jansen M, Delemarre-van de Waal HA, Verhoeven-Wind L, Frölich M, Oostdijk W, Wit JM.
    J Clin Endocrinol Metab; 2001 Jul 01; 86(7):2969-75. PubMed ID: 11443153
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.